Affimed, Genentech in NK cell engager deal

Affimed N.V. (NASDAQ:AFMD) said late Monday that it partnered with the Genentech Inc. unit of Roche (SIX:ROG; OTCQX:RHHBY) to develop and

Read the full 212 word article

User Sign In